Mullis, P E <br/><br/>
Half-life of exogenous growth hormone following suppression of endogenous growth hormone secretion with somatostatin in type I (insulin-dependent) diabetes mellitus.  [electronic resource] 

 -  Clinical endocrinology  Mar 1992 
 - 255-63 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0300-0664 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2265.1992.tb01441.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Depression, Chemical<br/>Diabetes Mellitus, Type 1--blood<br/>Female<br/>Glucose Clamp Technique<br/>Growth Hormone--blood<br/>Half-Life<br/>Humans<br/>Infusions, Intravenous<br/>Injections, Intravenous<br/>Male<br/>Somatostatin--pharmacology<br/>Time Factors